Literature DB >> 18324355

In vitro-in vivo correlation on delivery of drug candidates to articular cartilage.

Qin Wang1, Sonya Glasson, Uma Raut, Jamie Emerson, Tracey Blanchet, Gary Bridson, Richard Sheldon, Nevena Mollova, Elisabeth Morris, Xin Xu, Vikram S Patel.   

Abstract

PURPOSE: In the treatment of osteoarthritis (OA), some of the therapeutic approaches require delivery of drug(s) to the diseased cartilage. Presence of adequate drug levels in the cartilage is one of the important criteria in selection and ranking of lead compounds. The purpose of this study was to investigate the correlation in cartilage compound levels between in vitro experiments and in vivo animal studies.
MATERIALS AND METHODS: Bovine cartilage samples were incubated with test compounds of various concentrations in a culture medium, in the absence or presence of 25 mg/ml of serum albumin which served as an artificial synovial fluid (SF). The test compounds were also dosed to rabbits, the animal model used for efficacy studies, over a six-week treatment period. Test article concentrations in plasma, SF, and cartilage were determined by LC/MS/MS analysis. RESULTS AND
CONCLUSIONS: A correlation in cartilage drug concentration was observed between in vitro and in vivo studies. Plasma protein binding and the test article's affinity to cartilage were the major determining factors for drug delivery to cartilage in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324355     DOI: 10.1007/s11095-008-9557-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

Review 1.  Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid.

Authors:  R O Day; A J McLachlan; G G Graham; K M Williams
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Authors:  Yonghan Hu; Jason S Xiang; Martin J DiGrandi; Xuemei Du; Manus Ipek; Leif M Laakso; Jianchang Li; Wei Li; Thomas S Rush; Jean Schmid; Jerauld S Skotnicki; Steve Tam; Jennifer R Thomason; Qin Wang; Jeremy I Levin
Journal:  Bioorg Med Chem       Date:  2005-10-10       Impact factor: 3.641

3.  Articular diffusion of meloxicam after a single oral dose: relationship to cyclo-oxygenase inhibition in synovial cells.

Authors:  F Lapicque; P Vergne; J Y Jouzeau; D Loeuille; P Gillet; E Vignon; P Thomas; P Velicitat; D Türck; C Guillaume; A Gaucher; P Bertin; P Netter
Journal:  Clin Pharmacokinet       Date:  2000-11       Impact factor: 6.447

Review 4.  Articular pharmacokinetics of protein-bound antirheumatic agents.

Authors:  P A Simkin; M P Wu; D M Foster
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

5.  Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.

Authors:  Massimo Sabatini; Christophe Lesur; Marie Thomas; Agnès Chomel; Philippe Anract; Guillaume de Nanteuil; Philippe Pastoureau
Journal:  Arthritis Rheum       Date:  2005-01

6.  Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations.

Authors:  R O Day; H Francis; J Vial; G Geisslinger; K M Williams
Journal:  J Rheumatol       Date:  1995-12       Impact factor: 4.666

Review 7.  Clinical pharmacokinetics of tenoxicam.

Authors:  O G Nilsen
Journal:  Clin Pharmacokinet       Date:  1994-01       Impact factor: 6.447

Review 8.  The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.

Authors:  Jerry W Skiles; Nina C Gonnella; Arco Y Jeng
Journal:  Curr Med Chem       Date:  2004-11       Impact factor: 4.530

Review 9.  Aggrecanases and cartilage matrix degradation.

Authors:  Hideaki Nagase; Masahide Kashiwagi
Journal:  Arthritis Res Ther       Date:  2003-02-14       Impact factor: 5.156

Review 10.  Laboratory evaluation and interpretation of synovial fluid.

Authors:  Peter S MacWilliams; Kristen R Friedrichs
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-01       Impact factor: 2.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.